Overweight or obesity. Obesity
Conditions
Interventions
Intervention 1: Intervention group ( Melatonin, 3 milligrams, oral tablet, one tablet per day for 3 months). Intervention 2: Control group ( Placebo, oral tablet, one tablet per day for 3 months).
Treatment - Drugs
Placebo
Intervention group ( Melatonin, 3 milligrams, oral tablet, one tablet per day for 3 months)
Control group ( Placebo, oral tablet, one tablet per day for 3 months)
Sponsors
National Nutritional Research Institute
Eligibility
Sex/Gender
All
Age
19 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria (BMI between 25-35; Age between 19 and 55 years) Exclusion criteria (to be afflicted by thyroid dysfunctions and diabetes mellitus; consumption of drugs affecting body weight and body fat mass; to be afflicted by polycystic ovary syndrome and cushing syndrome; consumption of corticostroids, anti-depresssion drugs, contraceptive drugs, anti convulsion dugs and drugs affecting sleep pattern; consumption of alcohol; to be in the periods of pregnancy or lactation)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body weight. Timepoint: Baseline, 45 days after baseline, 3 months after baseline. Method of measurement: Weighing by weight scale.;Body fat mass percentage. Timepoint: Baseline, 45 days after baseline, 3 months after baseline. Method of measurement: BIA. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep hours. Timepoint: Baseline, 45 days after baseline, 3 months after baseline. Method of measurement: Questionnare.;Salivary Melatonin level. Timepoint: Baseline, 3 months after baseline. Method of measurement: ELISA kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSalman Mohammadi
Lorestan Universoty of Medical Sciences
Outcome results
None listed